Recently, novel inbred mouse strains that are genetically distinct from the commonly used models have been developed from wild-caught mice. These wild-derived inbred strains have been included in many of the large-scale genomic projects, but their potential as models of altered obesity and diabetes susceptibility has not been assessed. We examined obesity and diabetes-related traits in response to high-fat feeding in two of these strains, PWD/PhJ (PWD) and WSB/EiJ (WSB), in comparison with C57BL/6J (B6). Young PWD mice displayed high fasting insulin levels, although they had normal insulin sensitivity. PWD mice subsequently developed a much milder and delayed-onset obesity compared with B6 mice but became as insulin resistant. PWD mice had a robust first-phase and increased second-phase glucose-stimulated insulin secretion in vivo, rendering them more glucose tolerant. WSB mice were remarkably resistant to diet-induced obesity and maintained very low fasting insulin throughout the study. WSB mice exhibited more rapid glucose clearance in response to an insulin challenge compared with B6 mice, consistent with their low percent body fat. Interestingly, in the absence of a measurable in vivo insulin secretion, glucose tolerance of WSB mice was better than B6 mice, likely due to their enhanced insulin sensitivity. Thus PWD and WSB are two obesity-resistant strains with unique insulin secretion phenotypes. PWD mice are an interesting model that dissociates hyperinsulinemia from obesity and insulin resistance, whereas WSB mice are a model of extraordinary resistance to a high-fat diet. (Endocrinology 152: 3005-3017, 2011) O besity and diabetes have recently escalated in prevalence due to modern sedentary and "fast-food" lifestyles. These epidemic metabolic disorders are associated with many complications such as cardiovascular disease and place a great burden on healthcare systems (1-6). The pathophysiologies of obesity and type 2 diabetes are not fully understood. Some individuals are more resistant than others to developing these diseases despite a similar exposure to an obesogenic environment. Recent human genome-wide association studies have found genetic variants that alter disease susceptibility within this context (7-14); however, these variants account for only a small proportion of the genetic susceptibility to these diseases. Common forms of human obesity and diabetes are polygenic, involving gene-gene and gene-environment interactions (15, 16), and obesity and type 2 diabetes development occur over years or even decades and can be influenced by lifestyle factors throughout, making their study difficult.
O besity and diabetes have recently escalated in prevalence due to modern sedentary and "fast-food" lifestyles. These epidemic metabolic disorders are associated with many complications such as cardiovascular disease and place a great burden on healthcare systems (1) (2) (3) (4) (5) (6) . The pathophysiologies of obesity and type 2 diabetes are not fully understood. Some individuals are more resistant than others to developing these diseases despite a similar exposure to an obesogenic environment. Recent human genome-wide association studies have found genetic variants that alter disease susceptibility within this context (7) (8) (9) (10) (11) (12) (13) (14) ; however, these variants account for only a small proportion of the genetic susceptibility to these diseases. Common forms of human obesity and diabetes are polygenic, involving gene-gene and gene-environment interactions (15, 16) , and obesity and type 2 diabetes development occur over years or even decades and can be influenced by lifestyle factors throughout, making their study difficult.
To complement these studies, animal models can provide important insight into the pathophysiology of obesity and diabetes under controlled conditions (e.g. dietary manipulation), and their susceptibility for complex diseases falls on a continuum (17) . We have learned much about the pathophysiology of obesity and diabetes from mice harboring introduced gene mutations; however, the differences in disease risk between human individuals are more likely reflected in the set of naturally occurring genetic variants differing between mouse strains. Studies of inbred mouse strains have provided important insight into these diseases. For example, in C57BL6/J (B6) mice, obesity-induced insulin resistance is not sufficient for the development of overt diabetes because their ␤-cells have a high compensatory proliferative capacity (18, 19) . The NZO/HILtJ strain, a model of polygenic obesity and insulin resistance, has shown diabetes progression as a result of decompensation of ␤-cells in severely obese and hyperinsulinemic mice (20) . Alternatively, enhanced insulin secretion capacity in DBA/2J mice has been proposed to increase their risk of diabetes by accelerating ␤-cell exhaustion (21) . Although no model recapitulates the exact progression of disease seen in humans, each is valuable because they can provide insight into a specific process.
Large-scale genomics projects have revealed a genotypic diversity across all available mouse strains equivalent to that in humans (22) (23) (24) (25) (26) . However, only a small fraction of this is captured by the commonly used inbred strains. The wild-derived inbred mouse strains PWD/PhJ (PWD) and WSB/EiJ (WSB) were derived from more recently caught pairs of wild mice that have since been inbred for over 80 generations (26, 27) . These strains are genetically unique compared with the commonly used laboratory strains (22) (23) (24) (25) (26) . They represent an untapped source of variation and may harbor novel alleles that are determinants of disease risk and present novel combinations of alleles that are useful new models of disease. Type 2 diabetes and obesity susceptibility have not previously been studied in PWD and WSB mice (28 -30) . Here we examined PWD and WSB mice to determine whether they might provide new insight into obesity and diabetes susceptibility. We found that both strains were highly resistant to diet-induced obesity and displayed abnormal insulin secretion phenotypes compared with B6 mice. PWD mice had early hyperinsulinemia that preceded either obesity or insulin resistance. In contrast, WSB mice were able to maintain normal glucose tolerance despite very low insulin secretion. These findings suggest that these wild-derived inbred strains may provide new insight into the development of obesity and type 2 diabetes.
Materials and Methods

Animals
PWD, WSB, and B6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and bred in-house. Animals were housed in an environmentally controlled facility with 12-h light cycles (0700 -1900 h). Male mice were fed ad libitum a standard rodent chow (Teklad 2918; Harlan Laboratories Inc., Madison, WI) or a high-fat diet (HFD) containing 60% calories from lard and 20% calories from sugar (D12492; Research Diets Inc., New Brunswick NJ) from weaning. To randomize environmental variation, mice of all three strains consuming both diets were studied simultaneously, in cohorts generated over several months. All procedures were approved by the University of British Columbia Committee on Animal Care and were performed according to Canadian Council on Animal Care guidelines.
Body mass, body length, and body composition
Body mass was measured weekly. Ano-nasal length was measured in adult mice (20 wk of age). Body mass index (BMI), body mass (grams) divided by the square of body length (centimeters), was used to normalize body mass by body size. Analysis of body composition was performed by dual-energy x-ray absorptiometry (DEXA) with the PIXImus Mouse Densitometer (Inside Outside Sales, Madison, WI). Body composition was examined at 4, 7, 13, 16, 19, and 24 wk of age.
Measurement of plasma glucose, insulin, and adiponectin
Blood was collected at 4, 8, 14, 20 , and 24 wk of age for the measurement of plasma glucose and insulin levels. Mice were fasted for 4 h (0800 -1200 h), anesthetized briefly with isoflurane, and blood was collected rapidly from the saphenous vein into EDTA-containing tubes. Plasma was stored at Ϫ80 C for subsequent analyses. Plasma glucose and insulin levels were measured using commercially available kits (Autokit Glucose from Wako, Richmond, VA, and Mouse Insulin Ultrasensitive EIA from Alpco Diagnostics, Salem, NH) as per the manufacturer's instructions. Total and high molecular weight (HMW) adiponectin were measured using a commercially available kit (Mouse Adiponectin Total and High Molecular Weight ELISA; Alpco Diagnostics). The products of these assays were measured spectrophotometrically (Tecan Infinite M1000 microplate reader; Durham, NC).
Glucose tolerance tests
Intraperitoneal glucose tolerance tests (IPGTT) were performed at 10 and 16 wk of age. Mice were fasted for 4 h (0800 -1200 h), and then blood was collected for a basal plasma glucose measurement. An ip glucose bolus (1 g/kg body weight) was administered, and blood was collected from the saphenous vein at 15, 30, 60, and 120 min after injection to examine glucose and insulin contemporaneously. To quantify the total glucose clearance, we calculated the area between the normalized (baseline subtracted) glucose curve and the x-axis [area under the curve (AUC)] between 0 and 120 min. To quantify the second-phase insulin secretion, AUC for insulin was calculated between 15 and 120 min, using the 15-min value as baseline. We performed a similar short-course IPGTT on a second cohort of mice to investigate first-phase insulin secretion. Blood was collected basally and at 3, 5, 7, 10, and 15 min after glucose injection. We calculated AUC for insulin between 3 and 10 min from the baseline at 3 min.
values were normalized as a fraction of baseline. The cumulative fractional blood glucose clearance, the reverse AUC, was calculated as the area between baseline (fraction ϭ 1) and the glucose curve. Values are proportional to insulin sensitivity. Due to differential rates in glucose rebound, we calculated reverse AUC between 0 and 60 min.
Measurement of energy intake, total energy expenditure, and physical activity
Energy balance physiology was examined in 19-wk-old chow and HFD-fed mice using metabolic cages (PhenoMaster; TSE Systems, Bad Homburg, Germany). Mice were singly housed for 5 d for acclimatization. The cages were then placed in environmental control chambers at 21 C for measurement of oxygen and carbon dioxide gas exchange, physical activity (beam breaks), and food intake over 72 h; data from the first 24 h were discarded. Data from two full light and dark cycles were averaged. Total energy expenditure expressed as heat (kilocalories per hour) was calculated using the Weir equation: 3.941 ϫ VO 2 ϩ 1.106 ϫ VCO 2 , where VO 2 and VCO 2 are the volumes (ml/h) of O 2 consumed and CO 2 produced, respectively (31) . Food crumbs found in the bedding at the end of the experiment were hand-picked, weighed, and subtracted from the system-recorded value. Due to this spillage, it was not possible to analyze the meal patterns. Energy intake was calculated by multiplying the food intake by its caloric density supplied by its manufacturer.
Statistical analysis
We performed two-way ANOVA with strain and diet as the factors for measurements made at a specific age. For longitudinal measurements, we compared the effects of age, diet and strain using a two-way ANOVA with age and strain-diet combination (i.e. six groups) as the factors. Bonferroni posttests were conducted for the following: pair-wise comparisons between the strains within each diet; for each strain, comparisons of chow vs. HFD; and for comparisons of baseline measurements with all older ages for each strain-diet combination. For glucose and insulin tolerance tests, analyses were performed by one-way ANOVA with Tukey's multiple-comparison test to compare the three strains at each time point within each diet. For metabolic cage measurements we performed two-way ANOVA separately for the 24-h, light cycle, and dark cycle data, including lean and fat mass as covariates (32) (33) (34) , as indicated. Statistics were performed using Prism (version 5.03; GraphPad Software, La Jolla, CA) and Systat (version 13; Systat Software, Chicago, IL). P values Ͻ0.05 were considered significant, unless stated otherwise. Data are presented as means Ϯ SEM.
Results
PWD and WSB wild-derived inbred mice are resistant to diet-induced obesity
We examined the susceptibility of PWD and WSB mice to diet-induced obesity and diabetes compared with B6 mice. Body mass was reduced by 30% in chow-fed PWD and 16% in WSB mice compared with B6 mice at 4 wk of age (Fig. 1A) . B6 mice consuming the HFD were significantly heavier than their chow-fed counterparts from 7 wk of age, becoming 44% heavier by 26 wk of age. HFD-fed PWD mice displayed a delayed onset and milder obesity than B6 mice, becoming significantly heavier than chowfed PWD sibs from 14 wk of age and 26% heavier at 26 wk of age. Remarkably, body weights of HFD-fed WSB mice did not deviate from their chow-fed sibs. Increased body mass may reflect an increase in adiposity and/or body size. PWD and WSB mice had smaller body lengths than B6 mice (Fig. 1B) . BMI was significantly lower in PWD and WSB mice (Fig. 1C) , regardless of diet, suggesting they are not only smaller but also leaner. BMI was significantly increased in HFD-fed B6 mice and to a lesser extent in PWD mice, but not in WSB mice.
To directly assess adiposity, we performed DEXA (Fig.  1, D and E, and Supplemental Fig. 1 , published on The Endocrine Society's Journals Online web site at http:// endo.endojournals.org). Unexpectedly, at 4 wk of age, body fat was higher in PWD and WSB mice compared with B6 mice in both diet groups. We hypothesize this may be due to increased neonatal brown adipose tissue (BAT). To study the development of obesity in adult mice, we examined the subsequent change in body fat from 7 wk for both diet groups. In HFD-fed B6 mice, an established model of diet-induced obesity (35) , percent body fat rapidly increased between 7 and 13 wk of age and was significantly higher than in PWD and WSB mice from 13 wk of age (Fig.  1D) . Conversely, PWD mice displayed a more gradual increase. WSB mice remarkably maintained unaltered body fat throughout HFD feeding. Similar patterns were observed in chow-fed mice (Fig. 1E ). Although body fat gradually increased in chow-fed B6 mice, reaching significance by 16 wk of age, it did not change in chow-fed WSB mice or PWD mice, except for a small increase at 19 wk of age in the latter.
Average daily caloric intake in HFD-fed WSB mice was not different from that of B6 mice ( Fig. 2A and Supplemental Fig. 2 ). Intake was reduced in HFD-fed PWD mice compared with the other strains, suggesting this may contribute to their reduced obesity. Surprisingly, energy intake was highest in the chow-fed WSB mice. Total intake was increased in HFD-fed B6 mice compared with their chow-fed controls, but not in either PWD or WSB mice. To determine whether the differences in energy intake were in proportion to their lean and fat mass, we adjusted for these parameters independently by analysis of covariance (ANCOVA). These data show that B6 mice have a markedly increased consumption of the HFD for their body size that was not observed in PWD or WSB mice (Fig. 2B ). Metabolic fuel use was examined from their respiratory exchange ratios (RER). WSB mice fed the chow diet have a very efficient shift to near complete carbohydrate use during the active dark cycle ( Fig. 2C , P Ͻ 0.001 vs. light cycle) that was observed to a lesser degree in PWD mice (P Ͻ 0.001 vs. light cycle) and not in B6 mice. Predictably, RER were much lower in mice fed the HFD. Although HFD-fed B6 and PWD mice oxidize primarily fat on this diet, WSB mice still had increased carbohydrate use during the active cycle (P Ͻ 0.05 vs. light cycle). Total energy expenditure was increased in B6 mice on the HFD (Fig.  2D ). However, these mice are much larger. Thus, we adjusted energy expenditure for lean and fat mass by AN-COVA. Consistent with their increased food intake but lack of obesity, total energy expenditure tended to be increased in WSB mice (Fig. 2E ). Mean energy expenditure of PWD mice was intermediate to B6 and WSB mice. Physical activity was reduced in B6 mice consuming the HFD compared with chow-fed mice, whereas this was not observed in either PWD or WSB mice (Fig. 2, F-I ). Physical activity in WSB mice tended to be lower than in the other strains, suggesting that their increased energy expenditure is primarily metabolic, whereas increased physical activity may contribute to energy expenditure in PWD mice.
PWD and WSB mice have altered fasting plasma insulin levels compared with B6 mice
A second goal of these studies was to assess PWD and WSB mice for their susceptibility to diabetes. B6 mice, regardless of diet, had very low fasting insulin levels at 4 wk of age (Fig. 3A) . Fasting insulin levels progressively increased in HFD-fed B6. HFD-fed B6 mice were significantly hyperinsulinemic compared with their chow-fed sibs from 20 wk, with 2.6-fold higher fasting insulin by 24 wk of age. These increasing insulin levels with time likely reflect a compensation for insulin resistance that develops in response to obesity (36 -40) . Insulin levels also increased slightly over time in chow-fed B6 mice.
HFD-fed PWD mice had markedly higher fasting plasma insulin levels than B6 mice at 4 wk of age. Insulin was also increased in chow-fed PWD mice at 4 wk of age compared with B6 mice; however, this did not reach statistical significance. Insulin levels in HFD-fed PWD mice remained relatively constant until 14 wk of age but increased thereafter, coincident with the age at which body weights diverged between chow and HFDfed mice. Despite having significantly lower body fat at later ages, fasting plasma insulin levels did not differ significantly between HFD-fed PWD mice and HFD-fed B6 mice. HFD-fed WSB mice also had higher fasting plasma insulin levels than B6 mice at 4 wk of age, but they did not increase over time and were significantly lower than B6 mice at all other ages. They maintained fasting insulin levels similar to their chow-fed sibs except at 8 wk of age, when chow-fed WSB mice had transiently higher fasting insulin levels than their HFD-fed sibs (Fig. 3A) . High-fat feeding has been associated with elevated fasting glucose in B6 mice (41) . Fasting plasma glucose was increased in 8-, 20-, and 24-wk-old B6 mice consuming the HFD compared with 4 wk of age (Fig. 3B) and was higher than their chow-fed counterparts at 14 and 24 wk of age. Glucose was mildly increased in HFD-fed PWD mice compared with their chow-fed sibs, although it was significant only at 14 wk of age. The HFD did not affect fasting glucose levels in WSB mice over time. Although fasting glucose was similar between HFD-fed WSB and B6 mice at 4 wk, it was significantly lower in WSB mice at all older time points. Thus, although HFD-fed B6 mice were susceptible to developing 
FIG. 2.
Food intake and energy expenditure in PWD and WSB mice compared with B6 mice. A, Average daily caloric intake (n ϭ 6 -9 per group); B, average daily caloric intake adjusted independently for lean and fat mass (n ϭ 6 -9 per group); C, RER (respiratory quotients) during the light and dark phase. RER of 1.0 reflect oxidation of carbohydrate, whereas pure use of fat results in RER of 0.7. RER were significantly lower in all HFDfed mice compared with their corresponding chow-fed controls (P Ͻ 0.001; n ϭ 8 -14 per group). D, Total energy expenditure (n ϭ 7-14 per group); E, total energy expenditure adjusted independently for lean and fat mass (n ϭ 7-14 per group); F, physical activity measured as total beam breaks in the x-and y-axis (n ϭ 8 -14 per group); G, ambulatory physical activity, defined by breaks of adjacent beams; data are shown for the x-axis, which was very similar to that for the y-axis (n ϭ 8 -14 per group); H, fine movement or fidgeting activity, defined by repetitive breaks of the same beam; data are shown for the x-axis, which was very similar to that for the y-axis (n ϭ 8 -14 per group); I, rearing activity, defined as total beam breaks in the z-axis (n ϭ 7-14 per group). In B and E, statistics were performed by an ANCOVA, including lean and fat mass as covariates, and data are shown as the adjusted least square means Ϯ SEM. Metabolic analyses were performed at 19 -20 wk of age. Numbers of mice for some groups are reduced due to excessive food spillage that could not be accounted for or a sensor failure for a particular measurement. Data represent means Ϯ SEM. *, P Ͻ 0.05; ***, P Ͻ 0.001 vs. B6. ϩ, P Ͻ 0.05; ϩϩ, P Ͻ 0.01 PWD vs. WSB. PWD and WSB mice have better insulin sensitivity and glucose tolerance compared with B6 mice HFD-induced changes in insulin levels have been associated with the development of insulin resistance (36 -40) . We evaluated insulin sensitivity in HFD- (Fig. 4) and chowfed mice (Supplemental Fig. 3 ) at multiple ages. Insulin sensitivity was reduced in HFD-fed B6 mice compared with chow-fed controls as early as 6 wk of age. Insulin sensitivity decreased over time, especially between 16 and 26 wk of age in HFD-fed B6 mice, coinciding with increased fasting insulin (Fig. 3A) and their peak body fat (Fig. 1D) .
PWD mice fed the HFD had better insulin sensitivity than B6 mice at 6 and 10 wk of age (Fig. 4, A-D) . Thus, the higher fasting insulin levels in young PWD mice were not likely due to compensation for insulin resistance. Insulin sensitivity in HFD-fed PWD mice subsequently decreased at 16 wk (P Ͻ 0.01 vs. 6 wk; Fig. 4 , E and F) and 26 wk of age (P Ͻ 0.001 vs. 6 wk; Fig. 4, G and H) , despite their relatively mild diet-induced obesity. At 26 wk of age, HFD-fed PWD mice had only slightly better insulin sensitivity than HFD-fed B6 mice (Fig. 4H ) despite being much leaner (Fig. 1D) . Interestingly, in chow-fed PWD mice, insulin sensitivity decreased progressively up to 16 wk of age in the absence of obesity (P Ͻ 0.001 vs. 6 wk; Supplemental Fig. 3 ).
Insulin sensitivity increased with age in HFD-fed WSB mice (P Ͻ 0.001 at 16 wk; P Ͻ 0.05 at 26 wk vs. 6 wk of age; Fig. 4 ). By 26 wk of age, HFD-fed WSB mice demonstrated remarkable insulin sensitivity in comparison with HFDfed PWD and B6 mice (Fig. 4H , P Ͻ 0.001 vs. B6 and PWD). Chow-fed WSB mice had similar insulin sensitivity to their HFD-fed sibs that did not change over time. The maintenance of high insulin sensitivity observed in both chow and HFD-fed WSB mice is consistent with their low fasting plasma insulin levels throughout the study. Also notably, blood glucose rapidly returned to baseline between 60 and 120 min of the insulin tolerance test in all WSB mice (Fig. 4 and Supplemental Fig. 3) , suggesting a strong counterregulatory mechanism against rapidly depreciating glucose levels in WSB mice.
High-fat feeding has been associated with impaired glucose tolerance in B6 mice due to changes in both insulin sensitivity and secretion (42) . We performed IPGTT in B6, PWD, and WSB mice at 10 wk (Supplemental Fig. 4 ) and 16 wk of age (Fig. 5) . At 16 wk of age, HFD-fed B6 mice demonstrated impaired glucose tolerance (Fig. 5, A and B) , with glucose levels peaking at 60 min and still significantly elevated 2 h after injection. Consistent with their increased fasting insulin levels and higher insulin sensitivity, HFDfed PWD mice had markedly increased glucose tolerance (P Ͻ 0.001 vs. B6 and WSB fed the HFD). Plasma glucose peaked at 15 min at a much lower level and rapidly returned to baseline by 60 min. HFD-fed WSB mice had glucose tolerance intermediate to B6 and PWD mice. Their glucose peaked at 30 min after injection and returned to baseline levels by 120 min. Similar patterns were observed in chow-fed mice (Fig. 5, C and D) and at 10 wk of age (Supplemental Fig. 4) .
Impaired glucose tolerance in B6 mice has been associated with impaired insulin secretion (42) (43) (44) (45) . During the glucose challenge, we also measured in vivo insulin secretion (Fig. 6, A-D, and Supplemental Fig. 5 ). Consistent with their high fasting insulin, HFD-fed PWD mice had a stronger second-phase insulin secretion than B6 mice. HFD-fed WSB mice had the lowest basal fasting insulin and, surprisingly, lacked an obvious glucose-stimulated insulin secretion in vivo despite their glucose tolerance. We observed similar robust insulin secretion in chowfed PWD and B6 mice and an apparent absence of an insulin secretory response in chow-fed WSB mice (Fig.  6, C and D) .
Early-phase secretion has been proposed to play a greater role in postprandial glucose regulation (46 -49) but was not assessed in the time course above. To determine whether differences in early glucose clearance and the lack of secondphase secretion in WSB mice might be due to robust initial insulin secretion, we assessed first-phase insulin secretion in response to a similar in vivo glucose challenge. We observed a robust insulin secretion in HFD-fed and chow-fed PWD mice from approximately 3-10 min (Fig.  6, E-H) . First-phase secretion was impaired in chow-and HFD-fed B6 mice (Fig. 6 , E-H), consistent with the previously reported defective first-phase insulin secretion in this strain (42, 43, 45) . Remarkably, HFD-fed WSB mice also appeared to lack a first-phase insulin response to glucose, although chow-fed WSB mice had a small detectable insulin peak at 5 min (Fig. 6G) .
Adiponectin has insulin-sensitizing and glucose-clearing effects (50, 51) . At 4 and 20 wk of age, total plasma adiponectin levels were higher in chowand HFD-fed B6 mice compared with PWD and WSB mice (Fig. 7A) . Total adiponectin levels increased from 4 -20 wk of age in HFD-and chow-fed WSB and B6 mice but not PWD mice. HMW adiponectin and its ratio to total adiponectin have been suggested to promote insulin sensitivity (52) . Plasma HMW adiponectin was similar in chow-fed PWD, WSB, and B6 mice at 4 wk of age but was reduced in HFD-fed WSB mice compared with the other strains (Fig. 7B) . HFD-fed PWD mice had elevated HMW adiponectin compared with their chow-fed sibs, resulting in a significantly elevated HMW to total adiponectin ratio (Fig. 7C ). HMW adiponectin increased over time in all groups except for chow-fed B6 mice. At 20 wk of age, HMW adiponectin was still significantly lower in HFD-fed WSB mice than B6 and PWD mice (Fig.  7B) . The proportion of HMW adiponectin was significantly greater in chow-and HFD-fed PWD than B6 and WSB mice at 20 wk of age (Fig. 7C) . When plasma adi- ponectin levels were normalized to body fat (Fig. 7, D and E), we observed a significant decrease in total and HMW adiponectin in both HFD-fed B6 and PWD mice over time and compared with their chow-fed sibs, whereas adiponectin production was maintained in WSB mice.
Discussion
The wild-derived inbred mouse strains PWD and WSB are genetically unique and potentially novel disease models, yet their diabetes and obesity susceptibility had not been assessed. We examined their response to a 60% HFD compared with B6 mice. HFD-fed B6 mice develop obesity accompanied by hyperglycemia and hyperinsulinemia (41, 53) . Their obesity is correlated with insulin resistance and fasting hyperinsulinemia, and it is believed that the onset of obesity leads to the development of insulin resistance and concurrent compensatory hypersecretion of insulin, processes that worsen with increasing age and adiposity (45, 54 -56) . In contrast to this well-established model in B6 mice, HFD-and chow-fed PWD mice were hyperinsulinemic as early as 4 wk of age, while they had maximal insulin sensitivity. An increased ratio of HMW to total adiponectin may contribute to the enhanced insulin sensitivity in young PWD mice. Hyperinsulinemia in both diet groups was constant from 4 -14 wk and was accompanied by decreasing insulin sensitivity in the absence of obesity in chowfed mice as early as 10 wk. HFD-fed PWD mice progressively developed insulin resistance, reaching the same degree as B6 mice by 16 wk of age, although PWD mice had significantly lower body fat than B6 mice. This age was the onset of HFD-induced obesity in PWD mice. Fasting insulin then increased from 14 wk of age in HFD-fed PWD accompanied by further reductions in insulin sensitivity, suggesting these increases may be compensatory in nature. Thus, PWD mice have a primary hyperinsulinemia that preceded insulin resistance and obesity. It has previously been shown that insulin is required for fat storage in adipose tissue (57) , and hyperinsulinemia may cause insulin resistance (58 -60) . Chronic hyperinsulinemia in PWD mice could have caused insulin resistance and contributed to their development of obesity. PWD mice provide support for this model and represent a unique model that dissociates hyperinsulinemia from obesity and insulin resistance.
Young PWD mice displayed primary hyperinsulinemia. Fasting insulin levels were even higher in 4-wk-old HFDfed PWD mice compared with chow-fed PWD mice, consistent with reports that diets high in fat may independently increase insulin secretion (61) . Their hyperinsulinemia was associated with robust first-phase glucose-stimulated insulin secretion in vivo and increased secondphase secretion, although the magnitude of this response was highly variable. The high variability may have resulted from differences in insulin secretion dynamics between animals; if the nadir occurred before or after the time point used as baseline for the AUC measurement, this reduces the overall AUC. Additional studies will be required to determine whether the hyperinsulinemia in PWD is due to enhanced ␤-cell mass, increased ␤-cell insulin content, and/or altered secretion dynamics. Understanding these mechanisms might provide novel insight into mechanisms to enhance insulin secretion. It has been reported that mouse strains with high insulin secretion capacity also have increased risk for diabetes (21) In contrast, WSB mice, regardless of diet, displayed low fasting insulin at all ages. A transient increase in fasting insulin in chow-fed mice was observed at 8 wk of age, resulting in levels higher than observed in HFD-fed WSB mice. A similar increase was observed in chowfed B6 mice, and we speculate this may relate to transient mild insulin resistance and altered glucose metabolism at puberty (62, 63) . Low fasting insulin in WSB mice is consistent with their low body fat, normal insulin sensitivity, efficient metabolic fuel switching, and low fasting glucose levels, suggesting WSB mice are remarkably able to resist HFD-induced metabolic disturbances. Moreover, glucose tolerance was better in WSB than B6, despite the apparent absence of insulin secretion in response to an in vivo glucose challenge. Our glucose tolerance tests were performed by ip injection that bypasses the incretin response that augments insulin secretion in response to oral nutrients (64 -67) . It is possible that WSB have an increased reliance upon this mechanism to normally stimulate insulin secretion, which combined with their insulin sensitivity could be sufficient to respond to the glucose challenge. Alternatively, WSB mice may have an alternate mechanism for glucose clearance. Recent studies have shown that leptin administration to insulin-deficient rodents is capable of lowering glucose levels (68 -70) . Leptin also inhibits insulin secretion (71) in addition to its known roles in reducing body weight. It is thus possible that WSB mice have high leptin levels and/or sensitivity, which would also explain their lean phenotype. The ability to maintain adiponectin production over time with HFD feeding may also contribute to their insulin sensitivity and glucose tolerance (50, 52) . Ad- endo.endojournals.orgditional studies will be required to determine the mechanism by which WSB respond to a glucose challenge. After an insulin challenge in vivo, WSB mice had the steepest increase in plasma glucose from 30 -120 min across all the ages tested, particularly at 10 wk. This suggests WSB mice have a strong counterregulatory mechanism to guard against hypoglycemia that will require further investigation. Enhanced glucagon action could result from an increased ratio of glucagon to insulin due to their low insulin levels, or perhaps also increased glucagon secretion. It is also possible that absolute glucose levels more rapidly fell below the critical threshold at which counterregulatory mechanisms are enacted. In contrast, the rapid return of glucose to baseline levels could also reflect accelerated insulin clearance by the liver. The striking response at 10 wk may represent a transient enhancement of these factors and requires further investigation.
Circulating adiponectin decreases with adiposity due to a decrease in adiponectin mRNA expression in adipose tissue in rodents and humans (51, 72-74). We were surprised to find increased adiponectin in our HFD-fed B6 mice. However, HFD, insulin, and sugar, a component of our HFD, have all been shown to increase adiponectin (75) (76) (77) (78) (79) (80) (81) . The increased plasma levels could also be due to the increase in fat mass, which if greater in magnitude than the decrease in adiponectin mRNA expression could still result in an increase in circulating adiponectin. When normalized to total fat mass, plasma total and HMW adiponectin levels were reduced with age and adiposity in HFD-fed B6 and PWD mice but not in WSB mice. The ability to maintain adiponectin production in adipose tissue in HFD-fed WSB mice may contribute to their insulin sensitivity and glucose clearance.
WSB mice demonstrated extraordinary resistance to diet-induced obesity, whereas PWD mice had delayed and milder diet-induced obesity. HFD-fed WSB mice had increased energy expenditure compared with B6 mice (Fig. 2E) , although this did not reach statistical significance. HFD-fed PWD mice had reduced daily energy expenditure compared with HFD-fed B6 mice but not when adjusted for their body size. Neither wild-derived inbred strain displayed the hyperphagia or the decreased physical activity that were observed in response to the HFD in B6 mice, which may contribute to their obesity resistance. It is possible that differences in fat absorption could also contribute to their resistance; however, we have not observed any obvious differences in feces from these strains indicative of a major effect (Lee, K. T. Y., unpublished observations). Young HFD-fed PWD and WSB mice had higher body fat than B6 mice at 4 wk of age. DEXA does not differentiate between BAT and white adipose tissue. We speculate that the increased fat represents BAT, which is formed during fetal development to equip newborns with thermoregulatory ability (82) . Thermogenic BAT has been proposed to protect against obesity and has recently been recognized in humans (83) (84) (85) (86) (87) (88) (89) , and increased BAT could be a potential mechanism protecting PWD and WSB mice. Indeed, the increased energy expenditure in WSB mice is likely thermogenic, because physical activity was not increased (Fig. 2) . Elucidation of the molecular mechanisms by which these strains resist the effects of this obesogenic diet could provide insight into potential mechanisms to prevent the obesity epidemic we are facing today. 
FIG. 7.
Fasting plasma adiponectin levels in chow-and HFD-fed PWD and WSB mice compared with B6 mice at 4 and 20 wk of age. A, Total adiponectin (trimers, hexamers, and 12-mer to 18-mer HMW forms); B, HMW adiponectin; C, ratio of HMW to total adiponectin; D, total adiponectin normalized to total body fat mass; E, HMW adiponectin normalized to total body fat mass. Data represent means Ϯ SEM; n ϭ 7-8 per group. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001 vs. B6. ϩ, P Ͻ 0.05; ϩϩ, P Ͻ 0.01 PWD vs. WSB. #, P Ͻ 0.05; ##, P Ͻ 0.01; ###, P Ͻ 0.001 vs. 4 wk of age. In summary, the wild-derived inbred mouse strains PWD/PhJ and WSB/EiJ are both naturally occurring models of obesity resistance and altered insulin secretion. In the absence of obesity and insulin resistance, PWD mice have fasting hyperinsulinemia but later develop insulin resistance and mild obesity, suggesting primary hyperinsulinemia as a mechanism for the development of insulin resistance. In contrast, WSB mice are strikingly resistant to the metabolic effects of an obesogenic HFD and are able to maintain normal glucose tolerance despite undetectable insulin secretion in response to an ip glucose challenge in vivo. Thus, PWD mice are a valuable model of hyperinsulinemia dissociated from obesity and insulin resistance, whereas the remarkably lean and metabolically healthy phenotype of HFD-fed WSB warrants future investigation to understand their striking protection. Elucidation of the genetic and physiological mechanisms underlying these traits promises to lend new insight into the development of obesity and type 2 diabetes.
